22.06.2016Neuroaspis publication in E-Cronicon Neurology Journal

NEUROASPIS® Plp10 The Novel Nutraceutical Intervention as an Adjuvant Treatment for Multiple Sclerosis – “Specific PUFAs and antioxidant vitamins fulfil the criterion of biological plausibility and have the potential to diminish the severity and activity of MS symptoms, potentially even promoting recovery (remyelination)” https://www.ecronicon.com/eco16/pdf/ECNE-01-ECO-02.pdf

11.02.2015BMJ Open 2013 – Research Article

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial

22.05.2014Trends in Drug Research

Systems Medicine, Applying Systems Biology Approaches for Manipulation of Altered Biomechanisms towards Multiple Sclerosis Treatment by the Use of Specific Structured molecules and Antioxidant Vitamins: the PLP10 intervention Paradigm